tiprankstipranks
Trending News
More News >

Senzime AB Announces Q2 2025 Financial Report Presentation

Story Highlights
Senzime AB Announces Q2 2025 Financial Report Presentation

Don’t Miss TipRanks’ Half-Year Sale

Senzime AB ( (SE:SEZI) ) has shared an announcement.

Senzime AB has announced a webcast presentation of its second quarter 2025 financial report, scheduled for July 18. The presentation, led by CEO Philip Siberg, will provide insights into the company’s performance and will include a Q&A session, reflecting Senzime’s commitment to transparency and engagement with investors and stakeholders.

More about Senzime AB

Senzime is a leading medical device company established in 1999, specializing in precision-based monitoring systems that enhance perioperative patient safety, reduce costs, and improve outcomes. Their flagship product, the TetraGraph® system, is widely used in operating rooms worldwide for accurate neuromuscular transmission monitoring during surgery. Headquartered in Uppsala, Sweden, Senzime is publicly traded on the Nasdaq Stockholm Main Market and cross-traded on the US OTCQX Market.

Average Trading Volume: 321,021

Current Market Cap: SEK843.6M

Find detailed analytics on SEZI stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1